Promising pulmonary fibrosis treatment on path to clinical trials
02/26/2021 06:09 PM
Professor Fu Yu-show (standing). CNA photo Feb. 26, 2021
Taipei, Feb. 26 (CNA) A research team at Taiwan s National Yang Ming Chiao Tung University (NYCU) has transferred the technology for its experimental stem cell therapy treatment for pulmonary fibrosis to two biotech companies, in a first step toward beginning clinical trials, it announced Friday.
The research team led by Fu Yu-show (傅毓秀), a professor in the university s Institute of Anatomy and Cell Biology, first published details of its therapy, which involves transplanting stem cells collected from umbilical cord fluid into lungs affected by fibrosis, in the international medical journal Theranostics in 2019.